A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
about
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualizationExperimental medication treatment approaches for depression.Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine ReceptorN-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axisIdentification of IL6 as a susceptibility gene for major depressive disorder.Depression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens.Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study.Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study.Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder.Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.Association Between Interleukin-6 and Striatal Prediction-Error Signals Following Acute Stress in Healthy Female Participants.Resilience dysregulation in major depressive disorder: focus on glutamatergic imbalance and microglial activation.Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.Update on bipolar disorder biomarker candidates.Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.Is plasminogen activator inhibitor-1 a physiological bottleneck bridging major depressive disorder and cardiovascular disease?Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.Stress-Induced Microglia Activation and Monocyte Trafficking to the Brain Underlie the Development of Anxiety and Depression.Neuroinflammation and Oxidative Stress in Psychosis and Psychosis RiskInflammation Effects on Motivation and Motor Activity: Role of Dopamine.Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms.Biological hypotheses and biomarkers of bipolar disorder.A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia.Molecular hydrogen increases resilience to stress in mice.Psychosis: an autoimmune disease?Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.Childhood life events, immune activation and the development of mood and anxiety disorders: the TRAILS study.Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.Bipolar Spectrum Disorders in Male Youth: The Interplay between Symptom Severity, Inflammation, Steroid Secretion, and Body Composition.Pretreatment Serum MCP-1 Level Predicts Response to Risperidone in Schizophrenia.Visceral Inflammation and Immune Activation Stress the Brain.Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?
P2860
Q30236016-7A5336B7-EB73-46C9-8904-4027050B8271Q33635577-A0BCF931-AFF5-499D-B409-682A3266ABFDQ33740560-9FEF3B40-465C-4208-834C-407E9D2D09ACQ34543171-BB49B854-1611-4EC9-8AFF-A94FBE10500DQ34557243-BB1D71B0-FDF9-4A2D-970D-810B9405974DQ37159912-C7AF283A-9831-49A3-9152-76C5799CDC28Q37399810-48C0C323-83EC-4047-903B-3A3CF67128CFQ37456857-F8784822-E86D-4D12-AAA1-69975560D1B5Q37524068-3902C2AE-8148-4B70-90B0-F221D2F69E43Q37578777-03BEA6BA-BDFB-44F4-81EE-1CA4710BB362Q37653070-5529EFC9-C532-4DB3-AD4B-10256C874237Q38675991-783121FA-F769-4274-88C9-85A33FEFBF01Q38683601-354A075B-E883-418F-A3B5-1B00F08A154AQ38694251-BD34A6E9-5D4C-48F9-84A6-8001990A0468Q38726626-5265BAF5-EE36-4687-ABEC-F18069BB8559Q38803583-CB887B34-E3AD-4CCA-8F01-3E2848B13143Q38828405-73A6D590-9854-41A3-A116-06EAA1C8CA0CQ38849673-9B832727-8ED8-4436-9A1E-F27CC91B2CA9Q38853437-89E3B026-82B4-4C22-B5A5-94106C60FF07Q38879652-343CB962-69FC-426B-9D0C-A15FEF7A99A5Q38901529-B500B502-AC5A-4222-AD0C-881E0BAD8336Q38915253-06AB0018-839F-4F42-A0F8-0182409FB7D2Q38954644-58249799-CDA2-45CA-8403-2F679F70749CQ38954648-EE573FEB-A0B1-4CFC-9455-61862C845A4DQ38983429-4F98BF7D-630C-492C-9E7B-1405340C0077Q38991021-E198FE8F-0E50-463B-92DE-70B0401A4391Q38995726-C1AF2FDC-83F1-4A54-9C30-BB878D4A38BCQ39030393-8E82F671-0AD2-4490-96B6-C5DD11508E16Q39050960-52E1A04E-EC2F-4117-8220-654C2C5D1860Q39311969-800FE047-DC45-40B8-88D6-47A698F143C6Q39432877-539E8E7C-7D61-4C2D-B845-3BBE0675F7A6Q39867864-60014A65-A3B6-4D05-B429-9563A7D655D1Q40219036-45673F79-6D51-40A5-9C1E-E7FFA8EA9E1DQ40369760-3D739D51-FF29-4567-B278-C2D8B1D51716Q41974021-F30D4736-66D9-41A6-B68A-B8D3798D550FQ47101588-004FDD90-C8A7-4B56-A9C1-AD000F9A43A4Q47136379-51C21BDE-5087-445D-8E67-DB4983F992BCQ47137050-B55C02F7-45D0-4BD5-9ED3-9838C8BFEC35Q47152736-ECC2705E-093C-43A2-8642-A871A4826D66Q47155489-690E7433-CBFA-4C90-B72A-CDC288534E27
P2860
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A meta-analysis of blood cytok ...... polar disorder and depression.
@en
A meta-analysis of blood cytok ...... polar disorder and depression.
@nl
type
label
A meta-analysis of blood cytok ...... polar disorder and depression.
@en
A meta-analysis of blood cytok ...... polar disorder and depression.
@nl
prefLabel
A meta-analysis of blood cytok ...... polar disorder and depression.
@en
A meta-analysis of blood cytok ...... polar disorder and depression.
@nl
P2093
P2860
P921
P356
P1433
P1476
A meta-analysis of blood cytok ...... polar disorder and depression.
@en
P2093
B J Miller
D R Goldsmith
M H Rapaport
P2860
P2888
P304
P356
10.1038/MP.2016.3
P407
P577
2016-02-23T00:00:00Z